ReviR Therapeutics Raises ~$20M in Pre-A Financing

SOUTH SAN FRANCISCO, Calif.: SOUTH SAN FRANCISCO, Calif., Jan. 17, 2022 /PRNewswire/ -- ReviR Therapeutics, a South San Francisco based biopharmaceutical company, completed a Pre-A financing round with ~$20M. The funds will be used to advance the company's voyageRâ„¢ discovery platform, which integrates machine learning and RNA exploration at scale...

Click to view original post